Status:
COMPLETED
To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given Together
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18-80 years
Phase:
PHASE3
Brief Summary
This trial is conducted in Europe, Oceania, Africa, Asia and South America. This trial is designed to show the effect of treatment with liraglutide when adding to existing metformin therapy and to com...
Eligibility Criteria
Inclusion
- Subjects diagnosed with type 2 diabetes and treated with oral anti-diabetic drugs (OADs) for at least 3 months
- HbA1c: 7.0-11.0 % (both incl.) in subjects on OAD monotherapy. 7.0-10.0 % (both incl.) in subjects on OAD combination therapy
- Body Mass Index (BMI) less than or equal 40 kg/m2
Exclusion
- Subjects treated with insulin within the last three months
- Subjects with any serious medical condition
- Females of child bearing potential who are pregnant, breast-feeding or have the intention of becoming pregnant or not using adequate contraceptive methods
- Subjects using any drug (except for OADs), which in the Investigator's opinion could interfere with the glucose level (e.g. systemic corticosteroids)
Key Trial Info
Start Date :
May 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2008
Estimated Enrollment :
1091 Patients enrolled
Trial Details
Trial ID
NCT00318461
Start Date
May 1 2006
End Date
November 1 2008
Last Update
March 7 2017
Active Locations (190)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Ciudad Autonoma de Bs As, Argentina, C1405CWB
2
Novo Nordisk Investigational Site
Ciudad Autónoma de Bs As, Argentina, C1426ABP
3
Novo Nordisk Investigational Site
Ciudad Autónoma de BsAs, Argentina, C1406FWY
4
Novo Nordisk Investigational Site
Junín, Argentina, 6000